ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferencesView all Images (2)
AL amyloidosis - Nail and Distal Digit
See also in: Overview,External and Internal Eye,Oral Mucosal Lesion
Print Captions
Other Resources UpToDate PubMed

AL amyloidosis - Nail and Distal Digit

See also in: Overview,External and Internal Eye,Oral Mucosal Lesion
Print Images (2)
Contributors: Shari Lipner MD, PhD, Susan Burgin MD
Other Resources UpToDate PubMed

Alerts and Notices

Synopsis

AL amyloidosis : Fatigue, Hepatomegaly, Alkaline phosphatase elevated, Eyelid edema, Proteinuria, Ecchymosis, Paresthesias, Splenomegaly
Amyloidosis is caused by extracellular deposition of polymerized protein fibrils in various tissues and organs. Amyloid is organized into beta-plated sheets and, when viewed stained with Congo red dye and then viewed with polarized light, has apple-green birefringence. Amyloidosis may be limited to the skin (eg, lichen amyloidosis) or be systemic. The systemic type may be primary (AL amyloidosis) or secondary (AA amyloidosis). Amyloid proteins may deposit in almost any organ. Cutaneous manifestations are seen in 50% of patients with AL amyloidosis and may present with petechiae, ecchymoses, and purpura, particularly in the flexural areas, periorbital area, and sites of trauma. Other cutaneous signs are nodules or plaques, waxy papules, hypo- or hyperpigmentation, skin thickening, scleroderma-like changes, and bullae. AL amyloidosis generally has a poor prognosis, and causes of death are cardiac or renal failure. Median survival is 1-2 years, and < 5% of light chain amyloidosis patients survive more than 10 years.

Nail changes in amyloidosis are much less common than cutaneous manifestations. Nail dystrophy is secondary to nail matrix and bed amyloid deposition leading to faulty nail plate production. Nail dystrophy usually slowly worsens over time. In about one-half of cases, cutaneous manifestations precede nail changes. In about 25% of cases, nail changes may be the presenting sign of amyloidosis.

The most common underlying diagnosis in patients with nail changes is myeloma-associated systemic amyloidosis, followed by an underlying monoclonal gammopathy; in some cases, amyloidosis is idiopathic.

For nail dystrophy due to amyloidosis, there is a slight male predominance. It usually presents in the sixth or seventh decade (range: 49-81 years).

Related topics: multiple myeloma, monoclonal gammopathy

Codes

ICD10CM:
E85.81 – Light chain (AL) amyloidosis

SNOMEDCT:
23132008 – AL amyloidosis

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:10/15/2019
Last Updated:02/10/2021
Copyright © 2021 VisualDx®. All rights reserved.
AL amyloidosis - Nail and Distal Digit
See also in: Overview,External and Internal Eye,Oral Mucosal Lesion
Captions Print   View all Images (2)
(with subscription)
AL amyloidosis : Fatigue, Hepatomegaly, Alkaline phosphatase elevated, Eyelid edema, Proteinuria, Ecchymosis, Paresthesias, Splenomegaly
Clinical image of AL amyloidosis
Purpura on the medial eyelids and forehead.
Copyright © 2021 VisualDx®. All rights reserved.